相关实验视频

Updated: Jun 9, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

使用多光谱,热力学和模拟研究将药物 (科尔奇辛) 与L-阿斯巴拉金酶结合:可能与急性淋巴细胞白血病治疗有关

Ejlal Mohamed Abdullah¹, Farid Shokry Ataya¹, Md Tabish Rehman²

¹Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.

Luminescence : the journal of biological and chemical luminescence

|October 31, 2024

概括

这项研究揭示了胆固醇如何与L-asparaginase (L-ASNase) 相互作用,这种酶对于治疗急性淋巴细胞白血病 (ALL) 至关重要. 这些发现澄清了药物向结合,可能改善癌症疗法.

科学领域:

生物化学生物化学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

L-阿斯巴拉金酶 (L-ASNase) 是急性淋巴细胞白血病 (ALL) 的重要化疗剂.
了解与L-ASNase的药物相互作用对于优化癌症治疗疗效和最小化副作用至关重要.

研究的目的:

为了研究L-asparaginase (L-ASNase) 和素之间的分子相互作用和结构动力学.
阐明L-ASNase-colchicine复合物的结合机制,亲和力和热力学特性.
评估素结合对L-ASNase活性和构成的影响.

主要方法:

在不同温度 (298310 K) 的光灭光谱学.
福斯特共振能量转移 (FRET) 测量.
分子对接和100 ns分子动力学 (MD) 模拟.
循环二极化 (CD),同步和3D光光谱学.

主要成果:

胆固醇通过一种具有中等亲和力的静态火机制与L-ASNase结合 (Ka: 1.402.71 × 10^4 M−1).
热力学分析表明一种自发的结合过程 (ΔG°: -5.86 到 -6.03 kcal mol-1).
分子对接和MD模拟证实了稳定的1:1复合体,并揭示了特定的结合相互作用.
光谱分析显示,L-ASNase在结合菌素时的结构变化,酶活性略有下降25%.

结论:

胆固醇与L-asparaginase形成稳定的复合体,影响其结构并略微降低其活性.
对这种药物标相互作用的详细分子洞察力为开发癌症治疗中改进的治疗策略提供了基础.
这项研究促进了对化学疗法相关酶中药物诱导的构造变化的理解.

关键词:

斯特恩沃尔默的火常数急性淋巴细胞白血病急性淋巴细胞白血病癌症治疗疗法癌症治疗光灭的光灭分子对接和模拟的模拟.热力学分析热力学分析

更多相关视频

Modeling Chemotherapy Resistant Leukemia In Vitro

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...